
At Alder Therapeutics, we are on a bold mission to cure the incurable by bringing pluripotent stem cell-developed therapies to the benefit of patients. We are developing two promising allogeneic stem cell therapies, both with pre-clinical proof of concept data. Our lead program is a retinal cell therapy to treat Retinitis Pigmentosa, with a second program to tackle heart failure. Our industry-renowned team has decades of expertise in the scientific, technical and commercial aspects of bringing game-changing allogeneic cell therapies to market. Our focus is on de-risking cell therapy…
Annual Revenue$1M to $5M
Estimated OwnershipPublicBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.